Advanced search
Publication Cover
Leukemia & Lymphoma Volume 34, 1999 - Issue 5-6
Submit an article Journal homepage
70
Views
61
CrossRef citations to date
0
Altmetric
Original Article

Positron Emission Tomography (PET) for Staging and Evaluation of Response to Treatment in Patients with Hodgkin's Disease

Eckhart Weidmann Department of Medicine III, Hematology/Oncology, J.W Goethe University, Frankfurt/Main, Germany
,
Bianca B. Aican Department of Medicine III, Hematology/Oncology, J.W Goethe University, Frankfurt/Main, Germany
,
Andreas Hertel Division of Nuclear Medicine, Department of Radiology, J.W Goethe University, Frankfurt/Main, Germany
,
Richard P. Balm Division of Nuclear Medicine, Department of Radiology, J.W Goethe University, Frankfurt/Main, Germany
,
Kaiu Chow Department of Medicine III, Hematology/Oncology, J.W Goethe University, Frankfurt/Main, Germany
,
Bernhard Knupp Department of Infectiology, J.W Goethe University, Frankfurt/Main, Germany
,
Stefan Adams Division of Nuclear Medicine, Department of Radiology, J.W Goethe University, Frankfurt/Main, Germany
,
Gustav Hör Division of Nuclear Medicine, Department of Radiology, J.W Goethe University, Frankfurt/Main, Germany
,
Dieter Hoelzer Department of Medicine III, Hematology/Oncology, J.W Goethe University, Frankfurt/Main, Germany
&
Paris S. Mitrou Department of Medicine III, Hematology/Oncology, J.W Goethe University, Frankfurt/Main, Germany
 show all
Pages 545-551 | Accepted 20 Nov 1998, Published online: 01 Jul 2009

Citations (61)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Martin Hutchings. (2009) PET imaging in lymphoma. Expert Review of Hematology 2:3, pages 261-276.
Read now
Michelle Kim, Marcela V. Gronda, Hans A. Messner & James R. Ballinger. (2000) Accumulation of Sestamibi in Lymphoma Cell Lines In Vitro. Leukemia & Lymphoma 38:5-6, pages 599-603.
Read now

Articles from other publishers (59)

Kholood Abid Janjua, Raheem Shahzad & Adeeb Shehzad. 2022. Cancer Biomarkers in Diagnosis and Therapeutics. Cancer Biomarkers in Diagnosis and Therapeutics 277 343 .
N Ari Wijetunga, Brandon Stuart Imber, James F Caravelli, N George Mikhaeel & Joachim Yahalom. (2021) A picture is worth a thousand words: a history of diagnostic imaging for lymphoma. The British Journal of Radiology 94:1127.
Crossref
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2020) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2019) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews.
Crossref
Tomohiro Aoki & Christian Steidl. (2018) Novel Biomarker Approaches in Classic Hodgkin Lymphoma. The Cancer Journal 24:5, pages 206-214.
Crossref
Tarec Christoffer El-Galaly, Lars Christian Gormsen & Martin Hutchings. (2018) PET/CT for Staging; Past, Present, and Future. Seminars in Nuclear Medicine 48:1, pages 4-16.
Crossref
Andrea Gallamini, Martin Hutchings & Anna Borra. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 107 130 .
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Andrea Gallamini & Lale Kostakoglu. (2012) Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?. Blood 120:25, pages 4913-4920.
Crossref
Lale Kostakoglu. 2012. A Case-Based Approach to PET/CT in Oncology. A Case-Based Approach to PET/CT in Oncology 329 365 .
Martin Hutchings & Andrea Gallamini. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma 77 95 .
Lale Kostakoglu. 2011. Clinical PET-CT in Radiology. Clinical PET-CT in Radiology 265 291 .
Nidhi Sharma, Donald Neumann & Roger Macklis. (2008) The impact of functional imaging on radiation medicine. Radiation Oncology 3:1.
Crossref
Martin Hutchings & Lena Specht. (2008) PET/CT in the management of haematological malignancies. European Journal of Haematology 80:5, pages 369-380.
Crossref
. 2008. Oncologic and Cardiologic PET/CT-Diagnosis. Oncologic and Cardiologic PET/CT-Diagnosis 435 464 .
Einat Even-Sapir, Genady Lievshitz, Chava Perry, Yair Herishanu, Hedva Lerman & Ur Metser. (2007) Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin's Disease. Radiologic Clinics of North America 45:4, pages 697-709.
Crossref
Anna M. Kirby & N. George Mikhaeel. (2007) The role of FDG PET in the management of lymphoma: what is the evidence base?. Nuclear Medicine Communications 28:5, pages 335-354.
Crossref
Martin Hutchings, Annika Loft, Mads Hansen, Anne Kiil Berthelsen & Lena Specht. (2007) Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. European Journal of Haematology 78:3, pages 206-212.
Crossref
L. Kostakoglu, M. Coleman & S. J. Goldsmith. 2007. Clinical Nuclear Medicine. Clinical Nuclear Medicine 322 346 .
Gary J.R Cook, M. N Maisey, M. N Maisey & Vaseem Chengazi. 2006. Clinical Nuclear Medicine. Clinical Nuclear Medicine 761 762 .
Andreas K. Buck, Martin Bommer, Stephan Stilgenbauer, Malik Juweid, Gerhard Glatting, Holger Schirrmeister, Torsten Mattfeldt, Djurdja Tepsic, Donald Bunjes, Felix M. Mottaghy, Bernd J. Krause, Bernd Neumaier, Hartmut Döhner, Peter Möller & Sven N. Reske. (2006) Molecular Imaging of Proliferation in Malignant Lymphoma. Cancer Research 66:22, pages 11055-11061.
Crossref
Martin Hutchings, Annika Loft, Mads Hansen, Elisabeth Ralfkiaer & Lena Specht. (2006) Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematological Oncology 24:3, pages 146-150.
Crossref
Edita Kabickova, David Sumerauer, Eliska Cumlivska, Eva Drahokoupilova, Michaela Nekolna, Marketa Chanova, Marie Hladikova, Roman Kodet & Otakar Belohlavek. (2006) Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin’s disease. European Journal of Nuclear Medicine and Molecular Imaging 33:9, pages 1025-1031.
Crossref
Ursula Banning, Henryk Barthel, Christine Mauz-Korholz, Regine Kluge, Dieter Korholz & Osama Sabri. (2006) Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells. European Journal of Haematology 77:2, pages 102-108.
Crossref
P.L. Zinzani, M. Tani, S. Fanti, L. Alinari, G. Musuraca, E. Marchi, V. Stefoni, P. Castellucci, M. Fina, M. Farshad, S. Pileri & M. Baccarani. (2006) Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. Annals of Oncology 17:8, pages 1296-1300.
Crossref
Einat Even-Sapir, Genady Lievshitz, Chava Perry, Yair Herishanu, Hedva Lerman & Ur Metser. (2006) Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin's Disease. PET Clinics 1:3, pages 251-263.
Crossref
Guy Jerusalem & Roland Hustinx. 2006. The Lymphomas. The Lymphomas 189 202 .
Lale Kostakoglu & Stanley J. Goldsmith. 2006. Hodgkin’s and Non-Hodgkin’s Lymphoma. Hodgkin’s and Non-Hodgkin’s Lymphoma 363 412 .
Wolfgang Mohnike & Gustav Hör. 2006. PET/CT-Atlas. PET/CT-Atlas 341 362 .
Guy H. M. Jerusalem, Roland Hustinx & Pierre Rigo. 2006. Positron Emission Tomography. Positron Emission Tomography 125 145 .
Guy Jerusalem, Roland Hustinx, Yves Beguin & Georges Fillet. (2005) Positron emission tomography imaging for lymphoma. Current Opinion in Oncology 17:5, pages 441-445.
Crossref
Carmen R. Isasi, Ping Lu & M. Donald Blaufox. (2005) A metaanalysis of 18 F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphoma . Cancer 104:5, pages 1066-1074.
Crossref
Guy Jerusalem, Roland Hustinx, Yves Beguin & Georges Fillet. (2005) Evaluation of Therapy for Lymphoma. Seminars in Nuclear Medicine 35:3, pages 186-196.
Crossref
Toshiki Kazama, Silvana C. Faria, Vithya Varavithya, Sith Phongkitkarun, Hisao Ito & Homer A. Macapinlac. (2005) FDG PET in the Evaluation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls. RadioGraphics 25:1, pages 191-207.
Crossref
Young K. Lee, Gary Cook, Maggie A. Flower, Carl Rowbottom, Mehdi Shahidi, Bhupinder Sharma & Steve Webb. (2004) Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Radiotherapy and Oncology 73:3, pages 277-283.
Crossref
Mario Busetto, Guido Sotti, Pierluigi Zorat, Luigi Salvagno, Sandro Dal Fior, Fernando Gaion & Mariella Soraru. (2018) A Consensus Protocol: Image-improved Therapeutic Guidelines for Limited Adult Hodgkin's Disease. Tumori Journal 90:6, pages 630-636.
Crossref
Pietro Gabriele, Giuseppe Malinverni, Gian Luca Moroni, Marco Gatti, Daniele Regge, Annibale Versari, Desiderio Serafini, Alessandro Fraternali & Diana Salvo. (2018) The Impact of 18 F-deoxyglucose Positron Emission Tomography on Tumor Staging, Treatment Strategy and Treatment Planning for Radiotherapy in a Department of Radiation Oncology . Tumori Journal 90:6, pages 579-585.
Crossref
Martin Hutchings, Annika I. Eigtved & Lena Specht. (2004) FDG-PET in the clinical management of Hodgkin lymphoma. Critical Reviews in Oncology/Hematology 52:1, pages 19-32.
Crossref
Fumiyasu Yamamoto, Eriko Tsukamoto, Kunihiro Nakada, Toshiki Takei, Songji Zhao, Masahiro Asaka & Nagara Tamaki. (2004) 18p-FDG PET is superior to67Ga SPECT in the staging of non-Hodgkin’s lymphoma. Annals of Nuclear Medicine 18:6, pages 519-526.
Crossref
Ora Israel, Zohar Keidar & Rachel Bar-Shalom. (2004) Positron emission tomography in the evaluation of lymphoma. Seminars in Nuclear Medicine 34:3, pages 166-179.
Crossref
Peter Oehr, Hans-Jürgen Biersack & R. Edward ColemanC. Menzel. 2004. PET and PET-CT in Oncology. PET and PET-CT in Oncology 267 274 .
Jonathan W. Friedberg & Vaseem Chengazi. (2003) PET Scans in the Staging of Lymphoma: Current Status. The Oncologist 8:5, pages 438-447.
Crossref
Natascha Döbert, Christian Menzel, Uwe Berner, Nadja Hamscho, Nicola Wördehoff, Paris Mitrou & Frank Grünwald. (2003) Positron Emission Tomography in Patients with Hodgkin's Disease: Correlation to Histopathologic Subtypes. Cancer Biotherapy and Radiopharmaceuticals 18:4, pages 565-571.
Crossref
Lynny Yung & David Linch. (2003) Hodgkin's lymphoma. The Lancet 361:9361, pages 943-951.
Crossref
G. Jerusalem, Y. Beguin, M.F. Fassotte, T. Belhocine, R. Hustinx, P. Rigo & G. Fillet. (2003) Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease. Annals of Oncology 14:1, pages 123-130.
Crossref
M.J. O'Doherty, E.A. Macdonald, S.F. Barrington, N.G. Mikhaeel & S. Schey. (2002) Positron Emission Tomography in the Management of Lymphomas. Clinical Oncology 14:5, pages 415-426.
Crossref
Guy H.M. Jerusalem & Yves P. Beguin. (2002) Positron Emission Tomography in Non-Hodgkin's Lymphoma (NHL): Relationship Between Tracer Uptake and Pathological Findings, Including Preliminary Experience in the Staging of Low-Grade NHL. Clinical Lymphoma 3:1, pages 56-61.
Crossref
Elma Abella-Columna & Peter E. Valk. (2002) Positron emission tomography imaging in melanoma and lymphoma. Seminars in Roentgenology 37:2, pages 129-139.
Crossref
P. J. Hoskin. (2002) FDG PET in the management of lymphoma: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging 29:4, pages 449-451.
Crossref
Lale Kostakoglu, John P. Leonard, Ichiei Kuji, Morton Coleman, Shankar Vallabhajosula & Stanley J. Goldsmith. (2002) Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma. Cancer 94:4, pages 879-888.
Crossref
Martin R. WeihrauchDaniel ReKlemens ScheidhauerSascha AnsénMarkus DietleinStefanie BischoffHeribert BohlenJürgen WolfHarald SchichaVolker DiehlHans Tesch. (2001) Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood 98:10, pages 2930-2934.
Crossref
Martin R. WeihrauchDaniel ReKlemens ScheidhauerSascha AnsénMarkus DietleinStefanie BischoffHeribert BohlenJürgen WolfHarald SchichaVolker DiehlHans Tesch. (2001) Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood 98:10, pages 2930-2934.
Crossref
Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, José Thomas, Peter Vandenberghe, Jan Balzarini, Christine De Wolf-Peeters, Luc Mortelmans & Gregor Verhoef. (2001) Can positron emission tomography with [ 18 F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? . British Journal of Haematology 115:2, pages 272-278.
Crossref
Rachel Bar-Shalom, Maya Mor, Nikolai Yefremov & Stanley J. Goldsmith. (2001) The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Seminars in Nuclear Medicine 31:3, pages 177-190.
Crossref
M. Sandherr, C. von Schilling, T. Link, K. Stock, N. von Bubnoff, C. Peschel & N. Avril. (2001) Pitfalls in imaging Hodgkin’s disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose. Annals of Oncology 12:5, pages 719-722.
Crossref
Lale Kostakoglu. (2001) Commentary on “Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission Tomography”. Clinical Lymphoma 1:4, pages 307.
Crossref
Lale Kostakoglu & Stanley J. Goldsmith. (2000) Positron Emission Tomography in Lymphoma: Comparison with Computed Tomography and Gallium-67 Single Photon Emission Computed Tomography. Clinical Lymphoma 1:1, pages 67-74.
Crossref
Guy Jerusalem & Yves Beguin. (2000) Commentary on “Positron Emission Tomography in Lymphoma: Comparison with Computed Tomography and Gallium-67 Single Photon Emission Computed Tomography Imaging”. Clinical Lymphoma 1:1, pages 75-76.
Crossref
F. Moog. 2000. PET in Clinical Oncology. PET in Clinical Oncology 255 272 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.